NHLBI Funding & Resource Opportunities

national heart, lung and blood institute logo image

April 25 Webinar - NIH Commercialization Accelerator Program (CAP) for Phase II Awardees

Informational Webinar on Wednesday, April 25, 2018 at 2:00PM ET 

Register  HERE

Phase II SBIR/STTR Awardees

Are you a Phase II SBIR or STTR awardee? Do you anticipate Phase II SBIR or STTR funding by August 2018? If so, you may want to take advantage of the NIH Commercialization Accelerator Program (CAP). What is CAP?  It’s a technical assistance program where you (the awardee) work with a company NIH has engaged to help you plan out the next 18 months of your company’s growth.  Check out the latest full Notice: NOT-OD-17-097.  

Find out more during this webinar or reach out to:
J.P. Kim, J.D., M.B.A., M.P.P., M.Sc., M.A., jpkim@nih.gov 
National Institutes of Health (NIH), sbir@od.nih.gov


May 15 & 16 FDA REdI Spring Conference 2018

Register HERE

View the AGENDA

Regulatory Education for Industry (REdI) Conferences are a great way to learn what FDA’s Center for Drug Evaluation and Research or Center for Diagnostics and Radiological Health expect from companies developing new health products. These free, two-day events are held twice per year and can be attended in person or virtually. The next REdI conference will take place in San Francisco and will include the following topics:

  • CDER:  Nonclinical Assessment for Small Molecules and Biologic Drug Development; FDA Regulatory Requirements for Clinical Investigators; Communication Pathways; Inspections
  • CDRH: Digital Health; Design Controls; 510 (K) Program; Inspections

For more information, visit the event website: REdI Spring Conference 2018


June 1 Deadline - Concept to Clinic: Commercializing Innovation (C3i)

You can access specialized business frameworks and essential tools to successfully translate your technology from the lab to market by applying for the Concept to Clinic: Commercializing Innovation (C3i) funding supplement  PA-18-702.

Due Dates: June 1, 2018 and August 1, 2018, by 5:00PM ET

C3i’s curriculum and customized mentoring will guide you as you assess the commercial viability and potential business opportunity for your innovation, and will help define your value proposition in addressing an unmet market need.

More information is available in the full Funding Opportunity Announcement PA-18-702 and by contacting

Mike Pieck, PhD 
National Heart, Lung, and Blood Institute (NHLBI) 
Telephone: 301-827-7986 
Email: mike.pieck@nih.gov


Unfunded NIH Applicants get a Second Chance

NIH has partnered with Leidos Health’s Life Sciences to accelerate the biomedical research and development enterprise by matching high-scoring (e.g., those within the 30th percentile), unfunded NIH applications with private biomedical foundations and/or industries seeking to fund promising research through the Online Partnership to Accelerate Research (OnPAR).  

To learn more, please visit OnPAR


Did You Know?

The US Small Business Administration has developed resources to educate small businesses on many topics.  Specific programs that may be of interest to you include:

  • Legal Requirements for Small Business
  • How to Write a Business Plan
  • Market Research
  • Finding and Attracting Investors
  • Encore Entrepreneurship for Women

The full list of links to course materials including webinars and any associated worksheets or additional materials can be accessed: HERE


Aug 13 & 14 FDA Pediatric Medical Device Development Public Meeting

August 13 & 14, 2018
FDA White Oak Campus

REGISTER to attend this free event via webcast or in-person  

Are you developing a pediatric device?  If so, consider marking your calendar to attend this public meeting. Attendance can be in person (at FDA’s campus in Maryland) or virtual.  Hear the most current concerns and approaches FDA is exploring to enhance the complex development and innovation aspects of pediatric devices development.


Sept 5 Deadline - NIH SBIR/STTR 2018 Omnibus (Parent) Grant Solicitations

 SBIR:  PA-18-573  & PA-18-574

STTR:  PA-18-575 & PA-18-576

NIH has launched a new series of initiatives to enhance the accountability and transparency of clinical research. ALL applications, including SBIR/STTR, proposing any specific aims that meet NIH's definition of a clinical trial must now be submitted to a Funding Opportunity Announcement (FOA) that specifically states it accepts clinical trials. These initiatives target key points along the whole clinical trial lifecycle. READ the PHS 2018-2 SBIR/STTR Program Descriptions and Research Topics and learn more about these changes:  HERE

Deadlines: September 5, 2018; January 7, 2019; April 5, 2019

New NIH "FORMS-E" Grant Application Forms and Instructions for Due Dates On or After January 25, 2018. Read the Full Notice: NOT-OD-18-009

Two informational webinars archived:

1. HHS SBIR/STTR PHS 2018-2 Grant Omnibus Clinical Trial Webinar

2. HHS SBIR/STTR PHS 2018-2 Grant Omnibus Non-Clinical Trial Webinar

For more information, please contact NHLBI SBIR through our NHLBI Small Biz Inquiry Form and checkout our YouTube channel:  NHLBI Small Biz Hangouts


Oct 30 - Nov 1 Meet with NHLBI at the 20th Annual HHS SBIR/STTR Conference

October 30 - November 1, 2018
Dallas, Texas

Register HERE

This conference is relevant to a diverse audience, including biomedical entrepreneurs; principal investigators; grants and contracts administrators; and industry partners and investors.

Top 3 Reasons to Attend:

1.  Meet one-on-one with HHS SBIR/STTR program managers

Over 100 federal staff, including representatives from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Small Business Administration (SBA), Administration for Community Living (ACL), and HHS Office of the Inspector General (OIG) will be holding one-on-one meetings and giving presentations. You will have the chance to get one-on-one feedback about your technology proposal!

2.  Hear from successful HHS SBIR/STTR awardees 

Gain first-hand knowledge from experienced and successful applicants, potential funding partners and companies during interactive workshops and sessions. These sessions include a diverse group of successful awardees, including women-owned small businesses and socially and economically disadvantaged small businesses.

3.  Learn how to develop a competitive application

Many sessions focus on how to develop and submit your SBIR/STTR application. Topics include:

  • How to submit your SBIR/STTR grant proposal electronically via ASSIST
  • FDA regulatory requirements for drugs and devices
  • Important considerations to protect your intellectual property
  • Top 10 Dos and Don’ts for SBIR/STTR proposal development
  • Understanding indirect costs and financial accounting systems
  • What you need to know about human subjects and animal research
  • The differences between SBIR grants and contracts

Read more: HERE


Meet NHLBI Small Business Experts

04/18 - 04/20 – 2018 ACA Summit – Boston, MA

05/13 - 05/16SBIR/STTR Innovation Conference - Anaheim, CA

05/18 - 05/23ATS 2018 - San Diego, CA